MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/200/0.1/16.01.26 Stock MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/200/0.1/16.01.26
Add to a list
To use this feature you must be a member
Log inSign up

MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/200/0.1/16.01.26 Stock

Warrant

DE000ME9ZMZ9

Real-time Bid/Ask 11:09:33 2024-07-01 EDT
1.04 EUR / 1.05 EUR +4.50% Intraday chart for MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/200/0.1/16.01.26
Current month+29.87%
1 month+33.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart NOVO NORDISK A/S
Chart MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/200/0.1/16.01.26

Latest news about NOVO NORDISK A/S

Thinking about trading options or stock in Tesla, Microsoft, Novo Nordisk, Intel, or Solaredge Technologies? PR
Thinking about buying stock in NKGen Biotech, Novo Nordisk, SoundHound AI, Safety Shot, or Energy Fuels? PR
Thinking about buying stock in Estrella Immunopharma, Novo Nordisk, C4 Therapeutics, Plug Power, or LQR House? PR
Thinking about buying stock in Transphorm Technology, Stronghold Digital Mining, Broadcom, Novo Nordisk, or Datadog? PR
More news

Quotes 5-day view

Date Price Change
24-07-01 0.95 -5.00%
24-06-28 1 -0.99%
24-06-27 1.01 -0.98%
24-06-26 1.02 -5.56%
24-06-25 1.08 +17.39%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 09:19 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME9ZMZ
ISINDE000ME9ZMZ9
Date issued 2024-03-11
Strike 200 $
Maturity 2026-01-16 (564 Days)
Parity 10 : 1
Emission price 1.16 €
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.11 €
Lowest since issue 0.61 €
Delta0.33x
Omega 4.429
Premium46.32x
Gearing13.23x
Moneyness 0.7207
Difference Strike 54.37 $
Difference Strike %+27.19%
Spread 0.01 €
Spread %0.98%
Theoretical value 1.015
Implied Volatility 33.75 %
Total Loss Probability 79.80 %
Intrinsic value 0.000000
Present value 1.015
Break even 210.89 €
Theta-0.02x
Vega0.06x
Rho0.05x

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006 DKK
Average target price
949.7 DKK
Spread / Average Target
-5.56%
Consensus
  1. Stock Market
  2. Warrants
  3. Warrant